Fulvested 250 mg PFS Injection 5 ml belongs to the class of estrogen blockers used to treat breast cancer in postmenopausal women. Breast cancer is a type of cancer that develops when the breast cells begin to grow abnormally.

Fulvested 250 mg PFS Injection 5 ml contains Fulvestrant, which works by inhibiting some of the actions of estrogen (female sex hormone which may help cancer cells grow in women with breast cancer) and reducing the amount that is in the body. Thus, it helps in reducing breast cancer tumour growth.

Fulvested 250 mg PFS Injection 5 ml will be administered by a healthcare professional; do not self-administer. In some cases, Fulvested 250 mg PFS Injection 5 ml may cause certain common side effects such as injection site reactions like pain and/or inflammation, weakness, nausea, tiredness, headache or joint and musculoskeletal pain. Most of these side effects of Fulvested 250 mg PFS Injection 5 ml do not require medical attention and gradually resolve over time. However, if these side effects persist or worsen, please consult your doctor.

If you are allergic to Fulvestrant or any other medicines, please tell your doctor. Fulvested 250 mg PFS Injection 5 ml is not recommended for pregnant women as it may harm an unborn baby. Fulvested 250 mg PFS Injection 5 ml is contraindicated for use during lactation. Avoid alcohol consumption while receiving Fulvested 250 mg PFS Injection 5 ml. Avoid driving or operating machinery if you feel tired or weak after receiving Fulvested 250 mg PFS Injection 5 ml.

Fulvested 250 mg PFS Injection 5 ml contains Fulvestrant, used to treat breast cancer in postmenopausal women. Additionally, Fulvested 250 mg PFS Injection 5 ml may be used in combination with palbociclib to treat women with a type of breast cancer called hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer that is locally advanced or has spread to other parts of the body (metastatic).

If you are allergic to Fulvestrant or any other medicines, please tell your doctor. Fulvested 250 mg PFS Injection 5 ml is not recommended for pregnant women as it may harm an unborn baby. Using effective contraception while being treated with Fulvested 250 mg PFS Injection 5 ml and for two years after the last dose is advised. Fulvested 250 mg PFS Injection 5 ml is contraindicated for use during lactation. Avoid alcohol consumption while receiving Fulvested 250 mg PFS Injection 5 ml. Avoid driving or operating machinery if you feel tired or weak after receiving Fulvested 250 mg PFS Injection 5 ml.